Recent Advances for CAR T- Cell Therapy in R/R Multiple Myeloma

home / investigator-perspectives / recent-advances-for-car-t-cell-therapy-in-r-r-multiple-myeloma

Dr Dhakal provided an overview of the clinical hallmarks and risk stratification for R/R MM, as well as the current standard of care treatment options. He explored the role of CAR T-cell therapy in this setting, including an overview of the CAR-T process and criteria for identifying suitable patients.